Document Detail


The effects of post-heparin plasma lipases on anti-Xa clotting activity.
MedLine Citation:
PMID:  3992526     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of hepatic triglyceride lipase (HTGL) and lipoprotein lipase (LPL) on the anti-Xa clotting activity of plasma were studied. LPL had no effect, but HTGL enhanced anti-Xa activity. This enhancement was shown to be due to a time-dependent action of HTGL on lipoproteins. These results could explain the increases in anti-Xa clotting activity previously observed after injection of heparin analogues, SSHA and SP54, which are potent releasers of lipase enzymes.
Authors:
S P Williams; T W Barrowcliffe
Related Documents :
8969636 - Importance of standardization of lipase assays by using appropriate calibrators.
9431866 - Smoking and lipoprotein abnormalities on platelet aggregation in coronary heart disease.
3411246 - Platelet-enhanced apolipoprotein e production by human macrophages: a possible role in ...
8882346 - Inhibition of low density lipoprotein oxidation by myrigalone b, a naturally occurring ...
2331886 - Some effects of propane-1,2-diol on human platelets.
7495106 - Flurbinitroxybutylester: a novel anti-inflammatory drug has enhanced antithrombotic act...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Thrombosis research     Volume:  37     ISSN:  0049-3848     ISO Abbreviation:  Thromb. Res.     Publication Date:  1985 Feb 
Date Detail:
Created Date:  1985-06-10     Completed Date:  1985-06-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0326377     Medline TA:  Thromb Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  371-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Coagulation / drug effects
Factor X / antagonists & inhibitors*
Factor Xa
Heparin / diagnostic use*
Humans
Kinetics
Lipase / blood,  pharmacology*
Lipoprotein Lipase / blood,  pharmacology*
Liver / enzymology
Male
Rats
Chemical
Reg. No./Substance:
9001-29-0/Factor X; 9005-49-6/Heparin; EC 3.1.1.3/Lipase; EC 3.1.1.34/Lipoprotein Lipase; EC 3.4.21.6/Factor Xa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization red...
Next Document:  Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A.